Table 5. p-Stat3 and IL-17 Expression Are Not Correlated with CRC Patients’ Clinicopathological Characteristics.
Characteristics | n | p-Stat3 | χ2 | P value | IL-17 | χ2 | P value | ||
---|---|---|---|---|---|---|---|---|---|
0/1+ (%) | 2+/3+ (%) | 0/1+ (%) | 2+/3+ (%) | ||||||
Location | |||||||||
Colon | 43 | 24 (55.8) | 19 (44.2) | 1.3 | 0.261 | 28 (65.1) | 15 (34.9) | 3.4 | 0.065 |
Rectum | 52 | 23 (44.2) | 29 (55.8) | 24 (46.2) | 28 (53.8) | ||||
Age | |||||||||
<60 | 29 | 15 (51.7) | 14 (48.3) | <0.1 | 0.985 | 14 (48.3) | 15 (51.7) | 0.7 | 0.402 |
≥60 | 66 | 32 (48.5) | 34 (51.5) | 38 (57.6) | 28 (42.4) | ||||
Gender | |||||||||
Men | 52 | 27 (51.9) | 25 (48.1) | 0.3 | 0.600 | 27 (51.9) | 25 (48.1) | 0.4 | 0.545 |
Women | 43 | 20 (46.5) | 23 (53.5) | 25 (58.1) | 18 (41.9) | ||||
Differentiation | |||||||||
Moderately | 79 | 38 (48.1) | 41 (51.9) | 0.4 | 0.552 | 43 (54.4) | 36 (45.6) | <0.1 | 0.894 |
poorly | 16 | 9 (56.2) | 7 (43.8) | 9 (56.2) | 7 (43.8) | ||||
Lymphatic metastasis | |||||||||
Positive | 43 | 24 (55.8) | 19 (44.2) | 1.8 | 0.183 | 26 (60.5) | 17 (39.5) | 1.0 | 0.308 |
Negative | 52 | 23 (44.2) | 29 (55.8) | 26 (50.0) | 26 (50.0) | ||||
Clinical stage | |||||||||
I+II | 86 | 41 (47.7) | 45 (52.3) | 1.8 | 0.371 | 45 (52.3) | 41 (47.7) | 2.1 | 0.177 |
III+IV | 9 | 6 (66.7) | 3 (33.3) | 7 (77.8) | 2 (22.2) | ||||
General form | |||||||||
Ulcerative | 75 | 38 (50.7) | 37 (49.3) | 1.6 | 0.837 | 42 (56.0) | 33 (44.0) | 1.9 | 0.647 |
Protrude | 16 | 7 (43.8) | 9 (56.2) | 7 (43.8) | 9 (56.2) | ||||
Infiltrative | 3 | 1 (33.3) | 2 (66.7) | 2 (66.7) | 1 (33.3) | ||||
Colloid | 1 | 1 (100) | 0 (0) | 1 (100) | 0 (0) | ||||
Total cases | 95 | 47 (49.5) | 48 (50.5) | 52 (54.7) | 43 (45.3) |
Note: Strong positive cases (2+/3+) are compared with weak positive and negative cases (0/1+), respectively, using chi-square method.